We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

151 hedge funds and large institutions have $221M invested in BioDelivery Sciences International, Inc. in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $4.02M | Put options by funds: $1.64M

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

20% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 45

6% more funds holding

Funds holding: 143151 (+8)

5% more capital invested

Capital invested by funds: $210M → $221M (+$11.4M)

Holders
151
Holders Change
+8
Holders Change %
+5.59%
% of All Funds
2.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
54
Reduced
45
Closed
9
Calls
$4.02M
Puts
$1.64M
Net Calls
+$2.38M
Net Calls Change
-$603K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.47M +$812K +215,326 +113%
JMPWA
27
JP Morgan Private Wealth Advisors
California
$1.45M +$52.6K +13,949 +4%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.41M +$123K +32,631 +9%
AG
29
Algert Global
California
$1.25M +$362K +95,984 +38%
Schroder Investment Management Group
30
Schroder Investment Management Group
United Kingdom
$1.17M
GCP
31
GSA Capital Partners
United Kingdom
$1.03M +$523K +138,599 +95%
BCI
32
Brinker Capital Investments
Pennsylvania
$1M
Bank of America
33
Bank of America
North Carolina
$962K +$670K +177,514 +200%
RHJA
34
Rice Hall James & Associates
California
$874K -$47.2K -12,515 -5%
ECM
35
EMC Capital Management
Texas
$852K
PAM
36
Panagora Asset Management
Massachusetts
$830K +$18.6K +4,941 +2%
Morgan Stanley
37
Morgan Stanley
New York
$759K +$402K +106,586 +103%
CAM
38
ClariVest Asset Management
California
$690K -$4.9K -1,300 -0.7%
Principal Financial Group
39
Principal Financial Group
Iowa
$684K +$14.9K +3,943 +2%
Swiss National Bank
40
Swiss National Bank
Switzerland
$668K -$27.5K -7,300 -4%
WG
41
Winton Group
United Kingdom
$663K +$35.9K +9,516 +5%
Renaissance Technologies
42
Renaissance Technologies
New York
$654K -$267K -70,826 -28%
PPA
43
Parametric Portfolio Associates
Washington
$600K +$97.7K +25,902 +18%
Barclays
44
Barclays
United Kingdom
$599K +$130K +34,456 +26%
Victory Capital Management
45
Victory Capital Management
Texas
$578K +$327K +86,788 +118%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$573K +$601K +159,309 New
KF
47
Krilogy Financial
Missouri
$559K
American Century Companies
48
American Century Companies
Missouri
$515K +$75.8K +20,100 +16%
First Trust Advisors
49
First Trust Advisors
Illinois
$506K +$529K +140,179 New
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
$504K +$476K +126,273 +945%

BDSI Hedge Fund Activity: Q3 2021 in Review

151 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2021, worth a combined $221M — up 5.4% from $210M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BDSI positions and 9 closed out — a net gain of 8 holders — while 54 added to existing stakes and 45 trimmed.

The largest buyer was LSV Asset Management, opening a new position worth an estimated $7.26M. The largest seller was Goldman Sachs, cutting an estimated $5.33M.

  • 151 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2021, up from 143 in Q2 2021.
  • Funds reported $221M of BioDelivery Sciences International, Inc. stock for Q3 2021, up 5.4% quarter-over-quarter.
  • 17 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2021 and 9 closed out, a net change of +8 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2021 was LSV Asset Management, an estimated $7.26M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2021 was Goldman Sachs, an estimated $5.33M sold.

Based on aggregated 13F filings for Q3 2021.